Gotham Asset Management LLC Buys 107,720 Shares of Amedisys, Inc. (NASDAQ:AMED)

Gotham Asset Management LLC boosted its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 77.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 246,918 shares of the health services provider's stock after acquiring an additional 107,720 shares during the quarter. Gotham Asset Management LLC owned about 0.75% of Amedisys worth $22,418,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of AMED. Blue Trust Inc. grew its stake in Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after purchasing an additional 124 shares in the last quarter. HBW Advisory Services LLC acquired a new position in Amedisys during the fourth quarter valued at approximately $38,000. Johnson Financial Group Inc. acquired a new stake in shares of Amedisys in the fourth quarter worth $55,000. Vestcor Inc acquired a new stake in shares of Amedisys in the fourth quarter worth $73,000. Finally, Venturi Wealth Management LLC lifted its position in Amedisys by 397.4% in the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after purchasing an additional 779 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on AMED shares. Stephens restated an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Royal Bank of Canada reissued an "outperform" rating and set a $100.00 price objective on shares of Amedisys in a research report on Wednesday, April 16th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $100.75.

Amedisys Stock Performance

Shares of NASDAQ AMED traded down $0.56 during mid-day trading on Thursday, reaching $93.92. 84,007 shares of the company were exchanged, compared to its average volume of 415,831. The company's 50-day simple moving average is $93.13 and its 200-day simple moving average is $91.67. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $3.08 billion, a P/E ratio of 37.24, a P/E/G ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.12. The business had revenue of $594.78 million during the quarter, compared to analysts' expectations of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business's revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.03 EPS. As a group, research analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.